Integrated Discrimination Improvement (IDI) and Net Reclassification Index (NRI) analyses demonstrated a positive trend toward enhanced risk discrimination, although statistical significance was not reached ( Figure 4E ).
← all excerpts
Prognostic heterogeneity in ASXL1-mutated AML and refinement by an immunophenotype-based score.
2
—
—
The sentences
While cytarabine and venetoclax did not reach statistical significance, the overall distribution trended toward increased susceptibility among High-Score patients.